<?xml version="1.0" encoding="UTF-8"?>
<ref id="B63">
 <label>63.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Zhu</surname>
    <given-names>FC</given-names>
   </name>
   <span xml:space="preserve" class="x" xmlns="http://www.w3.org/1999/xhtml">, </span>
   <name name-style="western">
    <surname>Li</surname>
    <given-names>YH</given-names>
   </name>
   <span xml:space="preserve" class="x" xmlns="http://www.w3.org/1999/xhtml">, </span>
   <name name-style="western">
    <surname>Guan</surname>
    <given-names>XH</given-names>
   </name>
  </person-group>
  <etal/>
  <article-title>Safety, tolerability, and immunogenicity of a recombinant adenovirus Type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial</article-title>. 
  <source>Lancet</source>
  <volume>395</volume>(
  <issue>10240</issue>), 
  <fpage>1845</fpage>â€“
  <lpage>1854</lpage> (
  <year>2020</year>).
  <pub-id pub-id-type="pmid">32450106</pub-id>
 </mixed-citation>
</ref>
